83 related articles for article (PubMed ID: 2205265)
1. Stereoselective interaction of an azole antifungal agent with its target, lanosterol 14 alpha-demethylase (cytochrome P-45014DM): a model study with stereoisomers of triadimenol and purified cytochrome P-45014DM from yeast.
Yoshida Y; Aoyama Y
Chirality; 1990; 2(1):10-5. PubMed ID: 2205265
[TBL] [Abstract][Full Text] [Related]
2. Interaction of azole antifungal agents with cytochrome P-45014DM purified from Saccharomyces cerevisiae microsomes.
Yoshida Y; Aoyama Y
Biochem Pharmacol; 1987 Jan; 36(2):229-35. PubMed ID: 3545213
[TBL] [Abstract][Full Text] [Related]
3. 7-Oxo-24,25-dihydrolanosterol: a novel lanosterol 14 alpha-demethylase (P-45014DM) inhibitor which blocks electron transfer to the oxyferro intermediate.
Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
Biochim Biophys Acta; 1987 Dec; 922(3):270-7. PubMed ID: 3318933
[TBL] [Abstract][Full Text] [Related]
4. Deformylation of 32-oxo-24,25-dihydrolanosterol by the purified cytochrome P-45014DM (lanosterol 14 alpha-demethylase) from yeast evidence confirming the intermediate step of lanosterol 14 alpha-demethylation.
Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
J Biol Chem; 1989 Nov; 264(31):18502-5. PubMed ID: 2509459
[TBL] [Abstract][Full Text] [Related]
5. Modeling and interactions of Aspergillus fumigatus lanosterol 14-alpha demethylase 'A' with azole antifungals.
Gollapudy R; Ajmani S; Kulkarni SA
Bioorg Med Chem; 2004 Jun; 12(11):2937-50. PubMed ID: 15142553
[TBL] [Abstract][Full Text] [Related]
6. Sterol 14 alpha-demethylase and its inhibition: structural considerations on interaction of azole antifungal agents with lanosterol 14 alpha-demethylase (P-450(14DM)) of yeast.
Yoshida Y; Aoyama Y
Biochem Soc Trans; 1991 Aug; 19(3):778-82. PubMed ID: 1783215
[No Abstract] [Full Text] [Related]
7. Metabolism of 32-hydroxy-24,25-dihydrolanosterol by purified cytochrome P-45014DM from yeast. Evidence for contribution of the cytochrome to whole process of lanosterol 14 alpha-demethylation.
Aoyama Y; Yoshida Y; Sonoda Y; Sato Y
J Biol Chem; 1987 Jan; 262(3):1239-43. PubMed ID: 3543000
[TBL] [Abstract][Full Text] [Related]
8. Induction and substrate specificity of the lanosterol 14 alpha-demethylase from Saccharomyces cerevisiae Y222.
Wright GD; Honek JF
J Bacteriol; 1991 Feb; 173(3):1035-40. PubMed ID: 1846852
[TBL] [Abstract][Full Text] [Related]
9. Different substrate specificities of lanosterol 14a-demethylase (P-45014DM) of Saccharomyces cerevisiae and rat liver for 24-methylene-24,25-dihydrolanosterol and 24,25-dihydrolanosterol.
Aoyama Y; Yoshida Y
Biochem Biophys Res Commun; 1991 Aug; 178(3):1064-71. PubMed ID: 1872829
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective degradation and microbial epimerization of triadimenol in soils.
Li Z; Li Q; Zhao J; Wang W
Chirality; 2013 Jun; 25(6):355-60. PubMed ID: 23661341
[TBL] [Abstract][Full Text] [Related]
11. Inhibition by a novel azole antifungal agent with a geranyl group on lanosterol 14 alpha-demethylase of yeast.
Aoyama Y; Ishida K; Hori K; Sakaguchi A; Kudoh M; Yoshida Y
Biochem Pharmacol; 1992 Nov; 44(9):1701-5. PubMed ID: 1449529
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and antifungal activities of novel 1H-triazole derivatives based on the structure of the active site of fungal lanosterol 14 alpha-demethylase (CYP51).
Zhao QJ; Hu HG; Li YW; Song Y; Cai LZ; Wu QY; Jiang YY
Chem Biodivers; 2007 Jul; 4(7):1472-9. PubMed ID: 17638327
[TBL] [Abstract][Full Text] [Related]
13. Structure-based de novo design, synthesis, and biological evaluation of non-azole inhibitors specific for lanosterol 14alpha-demethylase of fungi.
Ji H; Zhang W; Zhang M; Kudo M; Aoyama Y; Yoshida Y; Sheng C; Song Y; Yang S; Zhou Y; Lü J; Zhu J
J Med Chem; 2003 Feb; 46(4):474-85. PubMed ID: 12570370
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of the azole-based fungicide flusilazole on yeast and mammalian lanosterol 14 alpha-methyl demethylase.
Trzaskos JM; Henry MJ
Antimicrob Agents Chemother; 1989 Aug; 33(8):1228-31. PubMed ID: 2679371
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of mammalian lanosterol 14 alpha-demethylase by RS-21607 in vitro and in vivo.
Swinney DC; So OY; Watson DM; Berry PW; Webb AS; Kertesz DJ; Shelton EJ; Burton PM; Walker KA
Biochemistry; 1994 Apr; 33(15):4702-13. PubMed ID: 8161528
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 14 alpha-sterol demethylase activity in Candida albicans Darlington does not correlate with resistance to azole.
Hitchcock CA; Barrett-Bee KJ; Russell NJ
J Med Vet Mycol; 1987 Oct; 25(5):329-33. PubMed ID: 3323450
[TBL] [Abstract][Full Text] [Related]
17. Expression and homology modeling of sterol 14alpha-demethylase from Penicillium digitatum.
Zhao L; Liu D; Zhang Q; Zhang S; Wan J; Xiao W
FEMS Microbiol Lett; 2007 Dec; 277(1):37-43. PubMed ID: 17986082
[TBL] [Abstract][Full Text] [Related]
18. Mode of action and resistance to azole antifungals associated with the formation of 14 alpha-methylergosta-8,24(28)-dien-3 beta,6 alpha-diol.
Kelly SL; Lamb DC; Corran AJ; Baldwin BC; Kelly DE
Biochem Biophys Res Commun; 1995 Feb; 207(3):910-5. PubMed ID: 7864896
[TBL] [Abstract][Full Text] [Related]
19. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Bartroli J; Turmo E; Algueró M; Boncompte E; Vericat ML; Conte L; Ramis J; Merlos M; García-Rafanell J; Forn J
J Med Chem; 1998 May; 41(11):1869-82. PubMed ID: 9599237
[TBL] [Abstract][Full Text] [Related]
20. Molecular modeling of azole antifungal agents active against Candida albicans. 1. A comparative molecular field analysis study.
Tafi A; Anastassopoulou J; Theophanides T; Botta M; Corelli F; Massa S; Artico M; Costi R; Di Santo R; Ragno R
J Med Chem; 1996 Mar; 39(6):1227-35. PubMed ID: 8632429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
